NasdaqGS - Nasdaq Real Time Price • USD
SpringWorks Therapeutics, Inc. (SWTX)
As of 3:57 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 521,048 | 13 |
| Sales | 49,237 | 3 |
| Net Shares Purchased (Sold) | 471,811 | 16 |
| Total Insider Shares Held | 1.65M | -- |
| % Net Shares Purchased (Sold) | 39.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PICHL DANIEL Officer | Sale at price 50.10 per share. | Direct | 751,550 | Feb 16, 2024 |
| PICHL DANIEL Officer | Conversion of Exercise of derivative security at price 27.64 per share. | Direct | 414,600 | Feb 16, 2024 |
| ASHAR BHAVESH Officer | Sale at price 43.75 - 49.32 per share. | Direct | 381,411 | Feb 5, 2024 |
| PICHL DANIEL Officer | Sale at price 43.81 - 46.44 per share. | Direct | 1,160,362 | Feb 2, 2024 |
| PICHL DANIEL Officer | Conversion of Exercise of derivative security at price 27.64 per share. | Direct | 449,150 | Feb 2, 2024 |
| WEINSTEIN HERSCHEL S General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| ISLAM SAQIB Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| NOFI MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| SMITH LESLEY MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| EDRIS BADREDDIN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| PICHL DANIEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| ASHAR BHAVESH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| PERIER FRANCIS I JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| CASSIDY JAMES Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| LIN TAI-AN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 4, 2024 |
| ISLAM SAQIB Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 30, 2023 |
| LIN TAI-AN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 2, 2023 |
| HAMBLETON JULIE Director | Sale at price 29.31 per share. | Direct | 70,876 | Jul 19, 2023 |
| SMITH LESLEY MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 30, 2023 |
| CASSIDY JAMES Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 30, 2023 |
| HAMBLETON JULIE Director | Sale at price 26.92 per share. | Direct | 64,603 | Jun 20, 2023 |
| LYNCH DANIEL S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| FUHRMAN ALAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| LEWIS-HALL FREDA C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| ALBAN CARLOS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| HAMBLETON JULIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| SCHWARTZ JEFFREY LAWRENCE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
| SCHWARTZ JEFFREY LAWRENCE Director | Sale at price 28.50 per share. | Indirect | 49,875,000 | Mar 16, 2023 |
| HAMBLETON JULIE Director | Sale at price 31.50 per share. | Direct | 34,841 | Mar 15, 2023 |
| PICHL DANIEL Officer | Sale at price 31.00 per share. | Direct | 26,598 | Jan 26, 2023 |
| WEINSTEIN HERSCHEL S General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| ISLAM SAQIB Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| NOFI MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| SMITH LESLEY MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| EDRIS BADREDDIN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| PICHL DANIEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| ASHAR BHAVESH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| PERIER FRANCIS I JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| CASSIDY JAMES Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 5, 2023 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 31.96 - 31.98 per share. | Indirect | 4,919,148 | Sep 12, 2022 |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 37.47 - 38.33 per share. | Indirect | 10,464,363 | Aug 9, 2022 |
| ALBAN CARLOS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 14, 2022 |
| SMITH LESLEY MARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 30, 2022 |
| BURGESS MICHAEL F Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 30, 2022 |
| SQUINTO STEPHEN P Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 19, 2022 |
| LYNCH DANIEL S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 19, 2022 |
| FUHRMAN ALAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 19, 2022 |
| LEWIS-HALL FREDA C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 19, 2022 |
| HAMBLETON JULIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 19, 2022 |
| SCHWARTZ JEFFREY LAWRENCE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 19, 2022 |
Related Tickers
APGE Apogee Therapeutics, Inc.
49.89
+2.56%
KRYS Krystal Biotech, Inc.
162.16
+3.12%
IMCR Immunocore Holdings plc
57.30
+2.65%
BPMC Blueprint Medicines Corporation
92.42
+2.00%
KYMR Kymera Therapeutics, Inc.
35.80
+4.22%
DYN Dyne Therapeutics, Inc.
25.53
+2.65%
ARVN Arvinas, Inc.
33.98
-2.64%
FDMT 4D Molecular Therapeutics, Inc.
24.79
-6.06%
SYRE Spyre Therapeutics, Inc.
34.33
+3.11%
ACLX Arcellx, Inc.
54.49
+4.79%